CONTI, GIULIA
CONTI, GIULIA
Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial
2013 Sardella, Gennaro; Lucisano, Luigi; Mancone, Massimo; Conti, Giulia; Calcagno, Simone; Stio, ROCCO EDOARDO; Pennacchi, Mauro; BIONDI ZOCCAI, Giuseppe; Canali, Emanuele; Fedele, Francesco
Evidence from the Resorbable-polymer stent versus Unresorbable-polymer stent Deployment for coronary Intervention: (RUDI-2) registry.
2014 Sardella, Gennaro; Carlo, Briguori; Roberto, Garbo; Enrico, Romagnoli; Pennacchi, Mauro; Donahue, MICHAEL EDWARD; Giacomo, Boccuzzi; Francesco, Summaria; Conti, Giulia; Canali, Emanuele; Placentino, Filippo; Stio, ROCCO EDOARDO; Lucisano, Luigi; BIONDI ZOCCAI, Giuseppe; Mancone, Massimo; Fedele, Francesco
Frequency of peripheral CD4+ CD25+ regulatory T cells is reduced in patients with ST-elevation myocardial infarction after placlitaxel-eluting stent implantation during primary PCI
2006 Sardella, Gennaro; Paroli, Marino; Conti, Giulia; Mancone, Massimo; Colantonio, Riccardo; Lucisano, Luigi; Pefrolini, A; Nguyen, BICH LIEN; DI ROMA, Angelo; Fedele, Francesco
Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE Experience (The RUDI Registry)
2011 Sardella, Gennaro; Conti, Giulia; Teodoro, Bisceglia; Canali, Emanuele; Mancone, Massimo; DE CARLO, Carlotta; Leonardo, Spedicato; Giorgio, Morocutti; Fedele, Francesco; Guglielmo, Bernardi
Rosuvastatin pre-treatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis. The ROMA trial.
2012 Sardella, Gennaro; Conti, Giulia; Donahue, MICHAEL EDWARD; Mancone, Massimo; Canali, Emanuele; DE CARLO, Carlotta; DI ROMA, Angelo; Calcagno, Simone; Lucisano, Luigi; Fedele, Francesco
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial | 2013 | Sardella, Gennaro; Lucisano, Luigi; Mancone, Massimo; Conti, Giulia; Calcagno, Simone; Stio, ROCCO EDOARDO; Pennacchi, Mauro; BIONDI ZOCCAI, Giuseppe; Canali, Emanuele; Fedele, Francesco | |
| Evidence from the Resorbable-polymer stent versus Unresorbable-polymer stent Deployment for coronary Intervention: (RUDI-2) registry. | 2014 | Sardella, Gennaro; Carlo, Briguori; Roberto, Garbo; Enrico, Romagnoli; Pennacchi, Mauro; Donahue, MICHAEL EDWARD; Giacomo, Boccuzzi; Francesco, Summaria; Conti, Giulia; Canali, Emanuele; Placentino, Filippo; Stio, ROCCO EDOARDO; Lucisano, Luigi; BIONDI ZOCCAI, Giuseppe; Mancone, Massimo; Fedele, Francesco | |
| Frequency of peripheral CD4+ CD25+ regulatory T cells is reduced in patients with ST-elevation myocardial infarction after placlitaxel-eluting stent implantation during primary PCI | 2006 | Sardella, Gennaro; Paroli, Marino; Conti, Giulia; Mancone, Massimo; Colantonio, Riccardo; Lucisano, Luigi; Pefrolini, A; Nguyen, BICH LIEN; DI ROMA, Angelo; Fedele, Francesco | |
| Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE Experience (The RUDI Registry) | 2011 | Sardella, Gennaro; Conti, Giulia; Teodoro, Bisceglia; Canali, Emanuele; Mancone, Massimo; DE CARLO, Carlotta; Leonardo, Spedicato; Giorgio, Morocutti; Fedele, Francesco; Guglielmo, Bernardi | |
| Rosuvastatin pre-treatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis. The ROMA trial. | 2012 | Sardella, Gennaro; Conti, Giulia; Donahue, MICHAEL EDWARD; Mancone, Massimo; Canali, Emanuele; DE CARLO, Carlotta; DI ROMA, Angelo; Calcagno, Simone; Lucisano, Luigi; Fedele, Francesco |